Overview
- Samsung announced at its Galaxy Unpacked keynote on July 22 that the existing Galaxy Ring will receive an FDA-cleared sleep apnea risk detection feature with a rollout planned for this fall.
- The feature combines the ring’s sensors with AI algorithms to identify breathing disruptions during sleep and will require several nights of calibration before it begins flagging possible risk.
- When signals consistent with sleep apnea are detected the ring will add an alert to the user’s morning report and advise them to consult a medical professional because the tool is a screening aid, not a clinical diagnosis.
- Samsung built the claim on precedent from its Galaxy Watch pathway, which won Korea MFDS approval in 2023, U.S. FDA clearance in February 2024, and reached users in 2025 after a staged rollout.
- The company frames the ring as the first over-the-counter smart ring with FDA-cleared sleep apnea detection, a distinction that sets it apart from rivals such as Oura and Ringconn that offer disturbance alerts but lack FDA clearance, though details on availability, pricing, and clinical performance are still pending.